Skip to content

Sleep, Circadian Rhythms and Cluster Headache

Characterisation of Sleep and Circadian Physiology in Individuals With Cluster Headache

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01447641
Enrollment
8
Registered
2011-10-06
Start date
2011-08-31
Completion date
2017-04-30
Last updated
2017-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cluster Headache

Keywords

Cluster Headache, Trigeminal Autonomic Cephalalgias, Sleep, Circadian Rhythms

Brief summary

The purpose of this study is to assess both the sleep and circadian (24-hourly biological rhythms) physiology of people with cluster headache. For sufferers with the episodic form of the disorder this will involve observation at two separate time points, once when experiencing attacks (in-bout) and once when attack free (out-of-bout). The study will include measurement of basic rest-activity patterns, sleep timing and timing of individual attacks, as well as a more detailed study recording sleep and circadian rhythms under clinical conditions over consecutive nights. Studying the differences in these processes in single individuals when they are both experiencing and free from attacks might provide insight into the brain mechanisms involved in triggering the bouts of attacks and individual attacks themselves. An improved understanding of this area may help design improved treatment options in future.

Interventions

OTHERPolysomnography

Overnight physiological recording of sleep

OTHERActigraphy

Wristwatch activity to measure basic rest activity cycle and sleep efficiency

Sponsors

University of California, San Francisco
CollaboratorOTHER
University of Surrey
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of cluster headache or closely related primary headache disorder

Exclusion criteria

* Abnormality on screening investigations that increase risk of participation * Alcohol consumption exceeding 21 units per week

Design outcomes

Primary

MeasureTime frame
amplitude and phase of circadian rhythm of melatonin36 hours

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026